ZYNERBA PHARMACEUTICALS INC (ZYNE)

US98986X1090 - Common Stock

1.3  +0.03 (+2.36%)

After market: 1.3015 +0 (+0.12%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

 MRQ
(2023-6-30)		 2022
(2022-12-31)		 2021
(2021-12-31)		 2020
(2020-12-31)		 2019
(2019-12-31)
ASSETS
Current Assets
Cash Equivalents
35.97M50.64M67.81M59.16M70.06M
Receivables
1.31M1.23M9.58M9.04M14.61M
Other Current Assets
2.02M2.91M2.83M5.17M2.38M
Total Current Assets
39.29M54.78M80.22M73.37M87.06M
 
Non-Current Assets
PPE Net
613.94K745.79K951.65K690.00K710.00K
Other Non-Current Assets
N/AN/AN/AN/AN/A
Total Non-Current Assets
1.18M745.78K951.65K690.00K700.00K
 
TOTAL ASSETS
40.48M55.52M81.17M74.06M87.76M
 
LIABILITIES
Current Liabilities
Short Term Debt
0.000.000.000.000.00
Current Portion Of LT Debt.
N/AN/AN/AN/AN/A
Accrued Expenses
8.98M7.23M8.11M11.39M7.32M
Accounts Payable
2.48M1.94M1.80M2.52M4.74M
Other Current Liabilities
N/AN/AN/AN/AN/A
Total Current Liabilities
11.46M9.17M9.90M13.91M12.06M
 
Non-Current Liabilities
Long Term Debt
0.000.000.000.000.00
Other Non-Current Liabilities
0.00119.52K353.69K0.00110.00K
Total Non-Current Liabilities
0.00119.53K353.69K0.00110.00K
 
TOTAL LIABILITIES
11.46M9.29M10.26M13.91M12.17M
 
SHAREHOLDERS' EQUITY
Retained Earnings
-295.41M-274.52M-239.48M-202.17M-150.84M
Additional Paid In Capital
324.37M320.70M310.35M262.29M226.41M
Common Shares
53.94K47.90K41.22K30.00K20.00K
Shares Outstanding
53.94M47.90M41.22M29.98M23.21M
Tangible Book Value per Share
0.540.971.722.013.26
Total Shareholders' Equity
29.02M46.23M70.91M60.14M75.60M
 
TOTAL LIABILITIES AND EQUITY
40.48M55.52M81.17M74.06M87.76M
 
Statistics
Current Ratio
3.435.978.105.277.22
Return On Assets (ROA)
-92.85%-63.10%-45.96%-69.32%-37.53%
Return On Equity (ROE)
-129.50%-75.79%-52.61%-85.37%-43.57%

All data in USD

Charts